These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17012892)
1. Maturation of recombinant hepatitis B virus surface antigen particles. Zhao Q; Wang Y; Freed D; Fu TM; Gimenez JA; Sitrin RD; Washabaugh MW Hum Vaccin; 2006; 2(4):174-80. PubMed ID: 17012892 [TBL] [Abstract][Full Text] [Related]
2. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667 [TBL] [Abstract][Full Text] [Related]
3. A novel application of ion exchange chromatography in recombinant hepatitis B vaccine downstream processing: Improving recombinant HBsAg homogeneity by removing associated aggregates. Kimia Z; Hosseini SN; Ashraf Talesh SS; Khatami M; Kavianpour A; Javidanbardan A J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1113():20-29. PubMed ID: 30877983 [TBL] [Abstract][Full Text] [Related]
4. Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. Gurramkonda C; Zahid M; Nemani SK; Adnan A; Gudi SK; Khanna N; Ebensen T; Lünsdorf H; Guzmán CA; Rinas U J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():104-11. PubMed ID: 24141044 [TBL] [Abstract][Full Text] [Related]
5. Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing. Zahid M; Lünsdorf H; Rinas U Vaccine; 2015 Jul; 33(31):3739-45. PubMed ID: 26079614 [TBL] [Abstract][Full Text] [Related]
6. Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment. Zhao Q; Wang Y; Abraham D; Towne V; Kennedy R; Sitrin RD Biochem Biophys Res Commun; 2011 May; 408(3):447-53. PubMed ID: 21527246 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the structural modifications accompanying the loss of HBsAg particle immunogenicity. Greiner VJ; Manin C; Larquet E; Ikhelef N; Gréco F; Naville S; Milhiet PE; Ronzon F; Klymchenko A; Mély Y Vaccine; 2014 Feb; 32(9):1049-54. PubMed ID: 24440114 [TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen. Manivel V; Ramesh R; Panda SK; Rao KV J Immunol; 1992 Jun; 148(12):4006-11. PubMed ID: 1376348 [TBL] [Abstract][Full Text] [Related]
9. Construction of atomic models of full hepatitis B vaccine particles at different stages of maturation. Berthier L; Brass O; Deleage G; Terreux R J Mol Graph Model; 2020 Jul; 98():107610. PubMed ID: 32302938 [TBL] [Abstract][Full Text] [Related]
10. Sodium dodecylsulfate polyacrylamide gel electrophoresis of recombinant hepatitis B surface antigen particles. Tleugabulova D J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):267-73. PubMed ID: 9613959 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus surface antigen binds to apolipoprotein H. Mehdi H; Kaplan MJ; Anlar FY; Yang X; Bayer R; Sutherland K; Peeples ME J Virol; 1994 Apr; 68(4):2415-24. PubMed ID: 8139027 [TBL] [Abstract][Full Text] [Related]
12. The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel. Greiner VJ; Ronzon F; Larquet E; Desbat B; Estèves C; Bonvin J; Gréco F; Manin C; Klymchenko AS; Mély Y Vaccine; 2012 Jul; 30(35):5240-5. PubMed ID: 22705175 [TBL] [Abstract][Full Text] [Related]
13. Aggregation of recombinant hepatitis B surface antigen in Pichia pastoris. Tleugabulova D; Falcón V; Sewer M; Pentón E J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):209-19. PubMed ID: 9824234 [TBL] [Abstract][Full Text] [Related]
14. Aggregation of recombinant hepatitis B surface antigen induced in vitro by oxidative stress. Tleugabulova D; Falcón V; Pentón E; Sewer M; Fleitas Y J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):153-66. PubMed ID: 10676995 [TBL] [Abstract][Full Text] [Related]
15. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen. Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785 [TBL] [Abstract][Full Text] [Related]
16. Assessing virus like particles formation and r-HBsAg aggregation during large scale production of recombinant hepatitis B surface antigen from Pichia pastoris. Hosseini SN; Sarvari T; Bashiri G; Khatami M; Shojaosadati SA Int J Biol Macromol; 2019 Oct; 139():697-711. PubMed ID: 31381908 [TBL] [Abstract][Full Text] [Related]
17. Nanoscale topography of hepatitis B antigen particles by atomic force microscopy. Milhiet PE; Dosset P; Godefroy C; Le Grimellec C; Guigner JM; Larquet E; Ronzon F; Manin C Biochimie; 2011 Feb; 93(2):254-9. PubMed ID: 20887766 [TBL] [Abstract][Full Text] [Related]
18. Membrane structure of the hepatitis B virus surface antigen particle. Satoh O; Imai H; Yoneyama T; Miyamura T; Utsumi H; Inoue K; Umeda M J Biochem; 2000 Apr; 127(4):543-50. PubMed ID: 10739944 [TBL] [Abstract][Full Text] [Related]
19. Improving the recovery of clarification process of recombinant hepatitis B surface antigen in large-scale by optimizing adsorption-desorption parameters on Aerosil-380. Hosseini SN; Ghaisari P; Sharifnia S; Khatami M; Javidanbardan A Prep Biochem Biotechnol; 2018; 48(6):490-497. PubMed ID: 29932813 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits. Cheong WS; Hyakumura M; Yuen L; Warner N; Locarnini S; Netter HJ Antiviral Res; 2012 Feb; 93(2):209-218. PubMed ID: 22138713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]